Ntanasis-Stathopoulos I, Nikolaou P-E, Filippatos C, Miliotis M, Kostopoulos IV, Bakouros P, Makridakis M, Liacos C-I, Nikolopoulos K, Laidou S, Chatzidimitriou A, Frantzi M, Kastritis E, Fotiou D, Gavriatopoulou M, Vlahou A, Hatzigeorgiou AG, Tsitsilonis O, Dimopoulos MA, Terpos E. Independent prognostic value of semaphorin-4D, interleukin-1β and complement activation in newly diagnosed multiple myeloma patients. haematol [Internet]. 2020Sep.10 [cited 2026Sep.16];. Available from: https://haematologica.org/article/view/14390